The independent source for health policy research, polling, and news.
121-140 of 212 results
People with diabetes say theyāve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
Californiaās stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said itās a āhuge relief.ā
When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often arenāt aware of cheaper options.
Amazon, along with a host of other technology companies, is working on ways to use its smart speaker devices to bring a range of health care services into your home.
Only about 12% of dialysis patients get their treatment at home and the initiative aims to dramatically increase that number and move patients out of costly dialysis centers. It would also add provisions to boost the annual number of kidneys available for transplants.
Though the candidates tended to agree on the end goal of universal coverage, differences emerged over how to get there.Ā
As people advance in age, the expectations for what constitutes good health change. People focus on positive emotions and satisfaction with life, while physical ailments play a less important role.
In reaction to an investigation by Kaiser Health News and the Chicago Tribune, the Illinois legislature has passed a new law to impose fines on nursing homes that fail to meet minimum staffing requirements.
In California, people who are black or Latino are more than twice as likely as whites to undergo amputations related to diabetes, a Kaiser Health News analysis found. The pattern is not unique to California.
Celina, Tenn., has long lured retirees, with its scenic hills and affordability. These newcomers help fuel the local economy. But a recent hospital closure makes the town a harder sell.
Critics are concerned about the explosion in controversial stem cell procedures offered by clinics ā and, increasingly, respected hospitals.
Executive editor Damon Darlin takes a spin as host of āThe Friday Breeze,ā whirling through a week of health care news so you donāt have to.
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
Doctors and patients say theyāre compelled to use off-label meds as research goes unfunded.
Older adults with advanced kidney disease sometimes want to stop dialysis but often meet resistance from doctors, new research shows. We explore options available to these patients, including conservative care.
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
A pilot program for frail low-income seniors provides much-needed help in dealing with ādaily activitiesā and offers practical solutions.
Whether because of illness or inactivity, many seniors need to up their protein game to maintain strength and mobility.
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from ābiosimilars.ā Itās a very different story in Europe.
Ā© 2026 KFF